Ann Intern Med

1. KIM GA, Lim YS
   Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B.
   Ann Intern Med. 2025;178:1365-1366.
   

   >> Share

   
   
2. HUANG SC, Kao JH
   Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B.
   Ann Intern Med. 2025;178:1364.
   

   >> Share

   
   
3. WANG J, Pan Y, Fan T, Wu C, et al
   Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B.
   Ann Intern Med. 2025;178:1364-1365.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

4. GUNAGAMBHIRE PV, Rudrappa M, Nayaka S
   Myco-nanofabrication of silver nanoparticles from Clonostachys byssicola PSEF1: Characterization, and exploration of its antimicrobial, antioxidant, anti-diabetic, anti-inflammatory and anticancer property on liver cancer cells.
   Biochem Biophys Res Commun. 2025;781:152544.
   

   >> Share

   
   
5. ZHAO Y, Wu XQ, Liao SL
   Rutaecarpine alleviates liver fibrosis by modulating the TRPV1/Connexin 43 axis: A study based on transcriptome data, single-cell sequencing data, and cell experiments.
   Biochem Biophys Res Commun. 2025;781:152506.
   

   >> Share

   
   
6. KIM MK, Kim H
   The insect peptide CopA3 enhances hepatocyte proliferation by directly binding to PTEN and inhibiting its activity.
   Biochem Biophys Res Commun. 2025;784:152639.
   

   >> Share

   
   

   
   BMC Cancer

7. ZHAO W, Li B, Gu Y, Jin X, et al
   The efficacy and safety of immune combination therapy in patients with driver gene-negative non-small cell lung cancer with liver metastasis: a systematic review and network meta-analysis.
   BMC Cancer. 2025;25:1332.
   

   >> Share

   
   

   
   BMC Gastroenterol

8. SEMEYA AA, Hafez RSAA, Ewais SHM, Mostafa SM, et al
   Screening for metabolic-associated fatty liver disease in type 2 diabetes patients using non-invasive scores and ultrasound: a cross-sectional study in Egypt.
   BMC Gastroenterol. 2025;25:639.
   

   >> Share

   
   

   
   Hepatology

9. PAN Z
   Letter to the editor: Technical considerations in the development of a multimodal deep learning model for predicting hepatocellular carcinoma outcomes.
   Hepatology. 2025 Sep 17. doi: 10.1097/HEP.0000000000001534.
   

   >> Share

   
   
10. NAKIB D, MacParland S
    Decoding the PSC fibrotic niche: Hepatocyte stress and metallothioneins.
    Hepatology. 2025 Jul 25. doi: 10.1097/HEP.0000000000001478.
    

    >> Share

    
    
11. DELTENRE P, Marot A, Henrion J
    A prognostic model in patients with alcohol-related cirrhosis does exist.
    Hepatology. 2025 Sep 17. doi: 10.1097/HEP.0000000000001532.
    

    >> Share

    
    
12. BJORNSSON ES, Devarbhavi HC
    Drug induced cholestatic liver diseases.
    Hepatology. 2024 Aug 8. doi: 10.1097/HEP.0000000000001052.
    

    >> Share

    
    
13. LEVY C, Bowlus CL
    Primary Biliary Cholangitis: personalizing second-line therapies.
    Hepatology. 2024 Nov 12. doi: 10.1097/HEP.0000000000001166.
    

    >> Share

    
    
14. RONCA V, Davies SP, Oo YH, Lleo A, et al
    The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects.
    Hepatology. 2025 Jan 3. doi: 10.1097/HEP.0000000000001225.
    

    >> Share

    
    
15. CANCADO GGL, Deeb M, Gulamhusein AF
    Liver transplantation for cholestatic liver diseases: Timing & disease recurrence.
    Hepatology. 2025 Feb 17. doi: 10.1097/HEP.0000000000001268.
    

    >> Share

    
    
16. MOL B, Werner E, Culver EL, van der Meer AJ, et al
    Epidemiological and economical burden of cholestatic liver disease.
    Hepatology. 2025 Apr 1. doi: 10.1097/HEP.0000000000001341.
    

    >> Share

    
    
17. TRAUNER M, Karpen SJ, Dawson PA
    Benefits and challenges to therapeutic targeting of bile acid circulation in cholestatic liver disease.
    Hepatology. 2025 Jul 2. doi: 10.1097/HEP.0000000000001438.
    

    >> Share

    
    

    
    J Comput Assist Tomogr

18. JENSEN CT, Wong VK, Likhari GS, Daoud TE, et al
    Novel Deep Learning Reconstruction to Augment Contrast Enhancement: Initial Evaluation.
    J Comput Assist Tomogr. 2025;49:698-704.
    

    >> Share

    
    
19. WANG H, Rubadeux D, Trout AT, Morin CE, et al
    Ultrasound-MRI Agreement in Individuals Undergoing Surveillance of Fontan-associated Liver Disease.
    J Comput Assist Tomogr. 2025;49:705-713.
    

    >> Share

    
    
20. HAN L, Zhang T, Liu X
    Multiparametric Dual-Energy CT for ALBI-Based Liver Function Stratification in Cirrhosis: Diagnostic Accuracy and Clinical Utility.
    J Comput Assist Tomogr. 2025 Sep 1. doi: 10.1097/RCT.0000000000001799.
    

    >> Share

    
    

    
    J Pediatr Surg

21. HUA Q, Ding Z, Xie H, Tang W, et al
    Correlation Analysis Between Preoperative Liver Ultrasound Elastography and Postoperative Jaundice clearance After Kasai Surgery for Biliary Atresia.
    J Pediatr Surg. 2025 Jul 12:162454. doi: 10.1016/j.jpedsurg.2025.162454.
    

    >> Share

    
    
22. GUPTA TK, Kumar B, Kanneganti P, Upadhyaya VD, et al
    Unconventional Alternative Shunts in Pediatric Extrahepatic Portal Vein Obstruction - Experience With Satisfactory Outcome.
    J Pediatr Surg. 2025;60:162462.
    

    >> Share

    
    

    
    PLoS One

23. MULLER-KUHNLE J, Schanz M, Schricker S, Benignus C, et al
    Predicting severe renal dysfunction in alcohol-associated cirrhosis: Comparative performance of liver function scores and machine learning models.
    PLoS One. 2025;20:e0332840.
    

    >> Share

    
    
24. HE Z, Cao J, Yu Y, Peng C, et al
    Role of endothelial cell markers in prognosis of hepatocellular carcinoma: Integrating bioinformatics analysis and experimental validation.
    PLoS One. 2025;20:e0331580.
    

    >> Share

    
    
25. XIE Y, Yang H, Lu S, Long G, et al
    The impact of proximity to major central hepatic vasculature on perioperative outcomes and size-based risk stratification in hepatic hemangioma surgery.
    PLoS One. 2025;20:e0332198.
    

    >> Share

    
    
26. LU X, Wang S, Du Y, Xie B, et al
    KYLO-0603, a novel liver-targeting, thyroid hormone receptor-beta agonist for the inhibition of MASH progression.
    PLoS One. 2025;20:e0331768.
    

    >> Share

    
    
27. XU C, Wang G, Zhang M, Lv L, et al
    Albumin-corrected anion gap as a predictive marker for mortality in critically Ill cirrhosis patients: an analysis based on the MIMIC-IV database.
    PLoS One. 2025;20:e0332490.
    

    >> Share

    
    
28. DU C, Wang H, Cao W, Yu Z, et al
    Perioperative and long-term outcomes of laparoscopic liver resection for combined hepatocellular carcinoma and cholangiocarcinoma versus intrahepatic cholangiocarcinoma: A propensity score matching analysis.
    PLoS One. 2025;20:e0328104.
    

    >> Share

    
    

    
    Transplant Proc

29. HASEGAWA Y, Obara H, Ojiro K, Kitago M, et al
    Trends and Barriers in Liver Transplantation for Patients With Decompensated Cirrhosis: A 15-Year Single-Center Cohort at a Japanese Center.
    Transplant Proc. 2025 Sep 16:S0041-1345(25)00453.
    

    >> Share

    
    
30. EGELI T, Unek T, Ozbilgin M, Agalar C, et al
    Evaluation of Etiology Based on Post-Transplant Pathological Diagnosis in Cases of Cryptogenic Cirrhosis.
    Transplant Proc. 2025 Sep 16:S0041-1345(25)00384.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share